[Problems on FDA phase IV drug evaluation of antipsychotic agents].
Kazematsuri
G
G
D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000331:legislation & jurisprudence / Q000592:standards; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy*
D014150:Antipsychotic Agents